Tvardi Therapeutics, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Tvardi Therapeutics, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, is 2.4 times its market value (net cash). Higher than 96% of Healthcare companies in United States.
- Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 92% of Healthcare companies in United States.
- Tangible Net Worth Ratio: Of every $100 of net worth, $98 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 89% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 2/3Sales grew in 0 of the last 3 years; profit grew in 2 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-202.6×Operating cash was negative last year, while some debt falls due within a year.
Lower than 92% of Healthcare companies in United States.
Cash Cushion Ratio
2.4× cashCash, after subtracting all debt, is 2.4 times its market value (net cash).
Higher than 96% of Healthcare companies in United States.
Tangible Assets Ratio
99%Of every $100 the company owns, $99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 89% of Healthcare companies in United States.
Tangible Net Worth Ratio
98%Of every $100 of net worth, $98 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 89% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Tvardi Therapeutics, Inc. made a loss over the last year. Tvardi Therapeutics, Inc. owes $0.52 for every $1 it owns. Tvardi Therapeutics, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossTvardi Therapeutics, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.55The share price is 1.55 times Tvardi Therapeutics, Inc.'s book value per share, lower than 67% of Healthcare companies in United States.
Market cap
$13 MThe total market value of all of Tvardi Therapeutics, Inc.'s shares at today's price (share price × number of shares), smaller than 85% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$8 MWhat Tvardi Therapeutics, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.63Net worth divided by the number of shares. The share price of $0.97 is 1.5 times this, which is the P/B above.
Return on equity (ROE)
-126.2%Tvardi Therapeutics, Inc. lost 126.2% of its shareholders' money over the last year, lower than 77% of Healthcare companies in United States.
Owes vs Owns
0.52×Tvardi Therapeutics, Inc. owes $0.52 for every $1 it owns (moderate), higher than 58% of Healthcare companies in United States.
Dividend yield
NoneTvardi Therapeutics, Inc. does not currently pay a dividend.
Profit growth
LossTvardi Therapeutics, Inc. made a loss in each of the last two years.
Cash vs debt
Net cashTvardi Therapeutics, Inc. held $31 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Tvardi Therapeutics, Inc.: $13 M ÷ $8 M (30 Jun 2026) = 1.5.
What is Tvardi Therapeutics, Inc.'s return on equity?
Tvardi Therapeutics, Inc. lost 126.2% of its shareholders' money over the last year, lower than 77% of Healthcare companies in United States.
How much does Tvardi Therapeutics, Inc. owe compared with what it owns?
Tvardi Therapeutics, Inc. owes $0.52 for every $1 it owns (moderate), higher than 58% of Healthcare companies in United States.
Does Tvardi Therapeutics, Inc. pay a dividend?
No. Tvardi Therapeutics, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.